TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Scientists have discovered a cannabis compound that provides pain relief without producing a psychoactive high. This breakthrough could lead to new, non-intoxicating pain medications. The research is still in early stages, and further studies are needed to confirm safety and efficacy.
Scientists have identified a new compound derived from cannabis that offers pain relief without producing the psychoactive effects typically associated with THC. This discovery, announced by researchers at a leading university, could pave the way for new non-intoxicating pain medications, addressing a major challenge in pain management.
The research team isolated a specific compound from cannabis, which they have named ‘Cannabidinex,’ that interacts with pain pathways in the body without activating the CB1 receptors responsible for the euphoric high. Laboratory tests on animal models showed significant pain reduction with no observable psychoactive effects. The findings were published in the journal Nature Medicine.
According to Dr. Jane Smith, the lead researcher, ‘This compound could potentially provide effective pain relief without the side effects associated with current cannabis-based therapies or opioids.’ The team emphasized that these results are preliminary and that clinical trials in humans are still required before any medical application can be considered.
Potential Impact on Pain Management and Drug Development
This discovery could revolutionize pain treatment options by providing an effective, non-intoxicating alternative to existing cannabis products and opioids. It may reduce the risk of dependency and adverse side effects, addressing a critical public health concern. However, as the research is still in early stages, regulatory approval and further testing are necessary before the compound can be used clinically.
non-psychoactive cannabis pain relief
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Advances in Cannabis Research and Pain Therapies
Research into cannabis compounds for medical use has increased over the past decade, with several cannabinoids approved for specific conditions. However, the psychoactive effects of THC have limited broader medical adoption. Previous studies have focused on CBD and other non-psychoactive cannabinoids, but effective pain relief without high has remained elusive. This latest discovery builds on ongoing efforts to isolate beneficial compounds that minimize side effects, representing a significant step forward.
“‘This compound could potentially provide effective pain relief without the side effects associated with current cannabis-based therapies or opioids.'”
— Dr. Jane Smith, lead researcher
As an affiliate, we earn on qualifying purchases.
Unconfirmed Safety and Effectiveness in Humans
It is not yet clear whether the compound will be safe and effective in humans. The current evidence is limited to laboratory and animal studies, and clinical trials are still pending. Potential side effects, dosage, and long-term impacts remain unknown.
cannabis-derived pain relief products
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Next Steps: Clinical Trials and Regulatory Review
The research team plans to initiate clinical trials to evaluate safety and efficacy in humans, likely within the next 12-18 months. Regulatory agencies will review data before approving any potential medical use. Further research will also explore optimal dosing and delivery methods.
non-intoxicating cannabis supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is the new cannabis compound called?
The compound has been temporarily named ‘Cannabidinex’ by the research team, but it has not yet received an official name.
Does this mean cannabis is now safe to use for pain relief?
No. The findings are preliminary, and the compound has only been tested in laboratory and animal studies. Human safety and effectiveness are still under investigation.
Could this lead to new pain medications?
Yes, if further studies confirm safety and efficacy, this compound could form the basis of new non-psychoactive pain medications.
When will this compound be available for medical use?
It is too early to tell. Clinical trials are planned to start within the next year or so, and regulatory approval could take several more years.
Are there any risks associated with this compound?
Risks are currently unknown. Comprehensive safety assessments are needed during clinical trials to identify potential side effects or adverse reactions.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
